Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
brain
Biotech
Angelini signs $550M-plus neuro pact with South Korean biotech
Angelini Pharma has worked out a $550 million-plus biobucks deal to get its hands on a Korean biotech’s preclinical neuro asset.
Gabrielle Masson
Sep 22, 2025 1:47pm
A cancer drug could be the first nonsurgical aneurysm treatment
Jun 14, 2023 2:00pm
Scientists make the case for 'intelligent' organoids in research
Mar 7, 2023 10:50am
Mapping brain genes in autism finds widespread changes
Nov 4, 2022 3:20pm
Researchers identify process that prevents brain injury deficits
Jul 8, 2022 4:51pm
Bioasis, Neuramedy sign blood-brain barrier pact for $72M
May 11, 2022 10:55am
